BETP is a small molecule agonist of the GLP-1 receptor, demonstrating activity with EC50 values of 0.66 µM and 0.755 µM at the human and rat receptors, respectively. It serves as a useful research tool for investigating GLP-1 receptor signaling and metabolic function in both in vitro and in vivo experimental models.